Butterfly Network (BFLY) director details Rule 10b5-1 insider share sales
Rhea-AI Filing Summary
Butterfly Network, Inc. director and 10% owner Jonathan M. Rothberg, Ph.D. reported multiple open‑market sales of Class A common stock made under a pre‑arranged Rule 10b5‑1 trading plan adopted on March 5, 2025 for estate planning purposes.
Through JAR TR, LLC, he sold 44,781 shares at a weighted average price of $4.0067 on 12/23/2025, 2,673 shares at $4.00 on 12/24/2025, and 14,911 shares at a weighted average price of $4.0098 on 12/26/2025. After these transactions, 1,157,764, 1,155,091 and then 1,140,180 Class A shares remained indirectly owned through JAR TR, LLC.
In addition, substantial indirect holdings of Class A and Class B common stock are reported through various entities, including 4C Holdings I–V, NVR TR, JNR TR, GBR TR, EJR TR, and the reporting person’s spouse, while Dr. Rothberg disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 14,911 | $4.0098 | $60K |
| Sale | Class A Common Stock | 2,673 | $4.00 | $11K |
| Sale | Class A Common Stock | 44,781 | $4.0067 | $179K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025 for estate planning purposes. Represents the weighted average sales price per share. The shares sold at prices ranging from $4.00 to $4.0243 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Dr. Rothberg is the Manager of 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC, 4C Holdings V, LLC, NVR TR, LLC, JNR TR, LLC, JAR TR, LLC, GBR TR, LLC and EJR TR, LLC, and is the spouse of Bonnie E Gould Rothberg MD. Dr. Rothberg disclaims beneficial ownership of the securities held by these persons and entities except to the extent of his pecuniary interest therein. Represents the weighted average sales price per share. The shares sold at prices ranging from $4.00 to $4.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
FAQ
What insider transaction did Butterfly Network (BFLY) report in this filing?
The filing reports that Jonathan M. Rothberg, Ph.D., a director and 10% owner of Butterfly Network, Inc., sold shares of Class A common stock in several transactions and updated his indirect beneficial holdings.
Was the Butterfly Network (BFLY) insider sale made under a Rule 10b5-1 trading plan?
Yes. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025, which the explanation notes was for estate planning purposes.
What is Jonathan Rothberg’s relationship to Butterfly Network (BFLY)?
Jonathan M. Rothberg, Ph.D. is listed as both a Director and a 10% Owner of Butterfly Network, Inc. in the filing.
What other entities associated with Jonathan Rothberg hold Butterfly Network (BFLY) shares?
The filing lists indirect holdings through 4C Holdings I, II, III, IV, V, LLC, NVR TR, LLC, JNR TR, LLC, GBR TR, LLC, EJR TR, LLC, and the reporting person’s spouse, Bonnie E Gould Rothberg MD, with Dr. Rothberg disclaiming beneficial ownership except for his pecuniary interest.